DK1976537T3 - Hæmostatisk materiale - Google Patents

Hæmostatisk materiale

Info

Publication number
DK1976537T3
DK1976537T3 DK06831418.6T DK06831418T DK1976537T3 DK 1976537 T3 DK1976537 T3 DK 1976537T3 DK 06831418 T DK06831418 T DK 06831418T DK 1976537 T3 DK1976537 T3 DK 1976537T3
Authority
DK
Denmark
Prior art keywords
hemostatic material
hemostatic
Prior art date
Application number
DK06831418.6T
Other languages
English (en)
Inventor
Craig Hardy
Edwin Lee Johnson
Paul Luksch
Original Assignee
Medtrade Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtrade Products Ltd filed Critical Medtrade Products Ltd
Application granted granted Critical
Publication of DK1976537T3 publication Critical patent/DK1976537T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK06831418.6T 2005-12-29 2006-12-19 Hæmostatisk materiale DK1976537T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0526505.3A GB0526505D0 (en) 2005-12-29 2005-12-29 Hemostatic material
PCT/GB2006/004776 WO2007074327A1 (en) 2005-12-29 2006-12-19 Hemostatic material

Publications (1)

Publication Number Publication Date
DK1976537T3 true DK1976537T3 (da) 2013-07-01

Family

ID=35841287

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06831418.6T DK1976537T3 (da) 2005-12-29 2006-12-19 Hæmostatisk materiale

Country Status (13)

Country Link
US (1) US7981872B2 (da)
EP (1) EP1976537B1 (da)
AU (1) AU2006329661B2 (da)
BR (1) BRPI0621164B8 (da)
CA (1) CA2635381C (da)
DK (1) DK1976537T3 (da)
ES (1) ES2417501T3 (da)
GB (1) GB0526505D0 (da)
MY (1) MY148836A (da)
PL (1) PL1976537T3 (da)
PT (1) PT1976537E (da)
WO (1) WO2007074327A1 (da)
ZA (1) ZA200806606B (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
WO2002102276A2 (en) 2001-06-14 2002-12-27 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US9204957B2 (en) 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
FR2897775B1 (fr) * 2006-02-24 2013-05-03 Elisabeth Laugier Biomateriau, implant injectable le comprenant, son procede de preparation et ses utilisations
JP2009538192A (ja) 2006-05-23 2009-11-05 プロビデンス ヘルス システム−オレゴン ディー／ビー／エー プロビデンス セント ビンセント メディカル センター 体の内腔または体の中空器官内に包帯構造を導入および適用するシステムおよび方法
US8932560B2 (en) 2007-09-04 2015-01-13 University of Maryland, College Parke Advanced functional biocompatible polymeric matrix used as a hemostatic agent and system for damaged tissues and cells
GB2461019B (en) * 2008-04-25 2013-06-05 Medtrade Products Ltd Haemostatic material
CN102076364B (zh) 2008-05-02 2014-07-02 普罗维登斯医疗卫生系统-俄勒冈州D/B/A普罗维登斯圣文森特医疗中心 创伤敷裹装置和方法
WO2010042540A1 (en) 2008-10-06 2010-04-15 Providence Health System - Oregon Foam medical devices and methods
US20110104279A1 (en) * 2009-11-04 2011-05-05 Marraccini Philip A Healing powder and method of use thereof
EP2498820B1 (en) 2009-11-13 2019-01-09 University of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds
TWI476018B (zh) * 2011-01-06 2015-03-11 Taiwan Textile Res Inst 微／奈米球狀止血材料及其製備方法
CA2914610C (en) 2013-03-13 2022-08-02 University Of Maryland Advanced functional biocompatible polymer putty used as a hemostatic agent for treating damaged tissue and cells
EP2968651B1 (en) * 2013-03-15 2020-10-21 Cook Medical Technologies LLC Adhesive medical products and methods for treating gastrointestinal lesions
US11931227B2 (en) 2013-03-15 2024-03-19 Cook Medical Technologies Llc Bimodal treatment methods and compositions for gastrointestinal lesions with active bleeding
GB2524299A (en) * 2014-03-19 2015-09-23 Medtrade Products Ltd Wound dressing
US9259357B2 (en) 2014-04-16 2016-02-16 Loma Linda University Composition, preparation, and use of chitosan shards for biomedical applications
WO2016049203A1 (en) * 2014-09-23 2016-03-31 Loma Linda University Composition, preparation, and use of chitosan power for biomedical applications
US10583216B2 (en) 2016-12-20 2020-03-10 Shilpa Medicare Limited Scaffold compositions for tissue repair
TR201713929A2 (tr) 2017-09-20 2019-04-22 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Ki̇tosan ve alji̇natin hemostati̇k kompozi̇syonlari
WO2019067680A1 (en) 2017-09-27 2019-04-04 Cook Medical Technologies Llc CROSSLINKING SUBMUCOSAL INJECTION SYSTEM
EP4218844A1 (en) 2018-01-12 2023-08-02 Boston Scientific Scimed, Inc. Powder for achieving hemostasis
US12263185B2 (en) 2018-02-05 2025-04-01 Bc3 Technologies, Inc. Hemostatic material and spray
CN115282327B (zh) * 2022-08-16 2023-11-10 常州华联医疗器械集团股份有限公司 一种湿性抗菌敷料
CN119367583A (zh) * 2024-10-24 2025-01-28 天津工业大学 一种基于多重非共价作用的自凝胶止血粉的制备

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56139423A (en) 1980-04-02 1981-10-30 Toyo Seiyaku Kasei Kk Hemostatic agent for dental oral use
US4394373A (en) 1981-04-06 1983-07-19 Malette William Graham Method of achieving hemostasis
US4532134A (en) 1981-04-06 1985-07-30 Malette William Graham Method of achieving hemostasis, inhibiting fibroplasia, and promoting tissue regeneration in a tissue wound
IT1261474B (it) * 1993-05-07 1996-05-23 Rosa Alfredo De Procedimento per la preparazione di biopolimeri iodurati con attivita'disinfettante e cicatrizzante, e biopolimeri iodurati cosi' ottenuti.
US5420197A (en) 1994-01-13 1995-05-30 Hydromer, Inc. Gels formed by the interaction of polyvinylpyrrolidone with chitosan derivatives
US5599916A (en) 1994-12-22 1997-02-04 Kimberly-Clark Corporation Chitosan salts having improved absorbent properties and process for the preparation thereof
US5836970A (en) * 1996-08-02 1998-11-17 The Kendall Company Hemostatic wound dressing
US6162241A (en) 1997-08-06 2000-12-19 Focal, Inc. Hemostatic tissue sealants
DE69938612T2 (de) * 1998-11-10 2009-07-09 Netech Inc., Kawasaki Funktionelle chitosanderivate
US6536448B2 (en) 2000-12-29 2003-03-25 Kimberly-Clark Worldwide, Inc. Hemostat coated dental floss and hemostat coated dental tape
WO2002102276A2 (en) 2001-06-14 2002-12-27 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US20050238702A1 (en) 2002-04-23 2005-10-27 Netech, Inc Medical composition containing photocrosslinkable chitosan derivative
EP1727569A1 (en) 2004-03-11 2006-12-06 Medtrade Products Ltd. Compositions of alpha and beta chitosan and methods of preparing them

Also Published As

Publication number Publication date
BRPI0621164B8 (pt) 2021-11-23
ZA200806606B (en) 2010-02-24
PL1976537T3 (pl) 2014-01-31
AU2006329661B2 (en) 2012-10-04
BRPI0621164A2 (pt) 2011-11-29
MY148836A (en) 2013-06-14
GB0526505D0 (en) 2006-02-08
CA2635381C (en) 2014-02-18
EP1976537A1 (en) 2008-10-08
AU2006329661A1 (en) 2007-07-05
US7981872B2 (en) 2011-07-19
CA2635381A1 (en) 2007-07-05
ES2417501T3 (es) 2013-08-08
BRPI0621164B1 (pt) 2019-10-08
WO2007074327A1 (en) 2007-07-05
US20090149422A1 (en) 2009-06-11
EP1976537B1 (en) 2013-04-03
PT1976537E (pt) 2013-05-22

Similar Documents

Publication Publication Date Title
DK1981511T3 (da) Hæmostatisk materiale
CY2020009I1 (el) Δεσμευτικοι παραγοντες σκληροστινης
SE0500031L (sv) Kompositmaterial
DK2752204T3 (da) Hæmostatisk materiale
EP1789217A4 (en) Sandwiched finstock
DK2214504T3 (da) Amfifilt polymert materiale
EP2045283A4 (en) HIGH REFRACTIVE INDEX MATERIAL
EP1874850A4 (en) Friction material
ZA200806606B (en) Hemostatic material
DE602006010862D1 (de) Filtermaterial
FR2873300B1 (fr) Materiau coupe-feu
DE602005004015D1 (de) Zerkleinerer
BRPI0520560B8 (pt) material dentário
ATE445582T1 (de) Werkstoffverbund
ITMI20061389A1 (it) Materiale per stampaggio
DE602006002968D1 (de) Thermoelektrisches material
EP1852183A4 (en) MULTIFUNCTIONAL MATERIAL
EP1923421A4 (en) SOUND INSULATING MATERIAL
AT501949A3 (de) Plastifiziereinheit
DE602005007329D1 (de) Schere
DE602006000058D1 (de) Fotothermografisches Material
FI20050653A0 (fi) Suodatinmateriaali
NO20054706D0 (no) Bygningsmateriale
FI20050547A0 (fi) Side
DE602006007259D1 (de) Schneidevorrichtung